|
Peripheral T-cell Lymphoma ... Angioimmunoblastic T-cell lymphoma ... Adult T-cell Lymphoma (also termed as adult T-cell leukemia or HTLV-1)
|
www.lymphomainfo.net/nhl/t-cell.html
www.lymphomainfo.net/nhl/t-cell.html
|
|
|
|
PURPOSE OF REVIEW: Although constitutively activated forms of the NOTCH1 receptor are potent inducers of T cell acute lymphoblastic leukemia/lymphoma when expressed in the bone marrow stem cells of mice, the known involvement of NOTCH1 in human T cell acute lymphoblastic leukemia/lymphoma has been restricted to very rare ...
|
www.medscape.com/medline/abstract/15548998
www.medscape.com/medline/abstract/15548998
|
|
|
Although there is a close association between Langerhans cell histiocytosis and malignant neoplasms, simultaneous occurrence of lymphoblastic lymphoma and Langerhans cell histiocytosis in the same lymph node is an extremely rare finding. ... The Medscape Journal ... Journals & Reference...
|
www.medscape.com/medline/abstract/11419987?queryText=la...
www.medscape.com/medline/abstract/11419987?queryText=langerhans%20cell%20histiocytosis
|
|
Overview: Lymphoblastic leukemias/lymphomas are neoplasms of precursor T cells and B cells, or lymphoblasts. The term lymphoblastic lymphoma (LBL) has been used to describe predominantly lymph node-based disease; ... Lymphoblastic lymphoma is aggressive and progresses rapidly, presenting as stage IV disease in more than...
|
emedicine.medscape.com/article/203556-overview
|
|
ALCL = anaplastic large cell lymphoma ; AITL Angioimmunoblastic T-cell lymphoma; Blastic = presenting in blood ; Cutaneous = presenting in skin ; Extranodal = other than lymph nodes; HTLV = human t-cell leukemia virus; ... ; Lymphoblastic Lymphoma ; (predominantly t-cell) / Blastic Lymphoma...
|
www.lymphomation.org/t-cell-types.htm
www.lymphomation.org/t-cell-types.htm
|
|
Background: Controversy exists regarding the role of high-dose therapy followed by stem-cell transplant (SCT) in the treatment of T-cell lymphoblastic lymphoma (T-LBL). We conducted an intention-to-treat analysis of the strategy of SCT as definitive treatment of T-LBL.
|
annonc.oxfordjournals.org/cgi/content/abstract/18/3/535
annonc.oxfordjournals.org/cgi/content/abstract/18/3/535
|
|
INDICATION[1]; ARRANON® (nelarabine) Injection is indicated for the treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.
|
www.arranon.com/hp/hp040_LBL.html
|
|
T-cell lymphoblastic lymphoma (T-LBL), a type of cancer of the blood, is the most common childhood lymphoma. The use of intensive chemotherapy drugs, usually with some radiation therapy to the affected area, results in survival with no recurrence (return) of disease in 60 to 70% of patients.
|
www.ufscc.ufl.edu/Patient/cancernews.aspx?section=cance...
www.ufscc.ufl.edu/Patient/cancernews.aspx?section=cancernews&id=18390
|
|
Deletions of chromosome 6q have been reported in several hematological malignancies, but data are not conclusive regarding their biological and prognostic impact. Therefore, we focused on pediatric patients diagnosed with T-cell lymphoblastic lymphoma (T-LBL) treated uniformly according to the NHL-BFM95 protocol.
|
www.nature.com/doifinder/10.1038/sj.leu.2404275
|
|
